Compare AVAH & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAH | QDEL |
|---|---|---|
| Founded | 1984 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2021 | N/A |
| Metric | AVAH | QDEL |
|---|---|---|
| Price | $7.69 | $28.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 6 |
| Target Price | $10.56 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 03-12-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | $2,290,591,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $21.81 | N/A |
| Revenue Next Year | $5.96 | $2.28 |
| P/E Ratio | $20.95 | ★ N/A |
| Revenue Growth | ★ 15.48 | N/A |
| 52 Week Low | $3.67 | $19.50 |
| 52 Week High | $10.32 | $44.68 |
| Indicator | AVAH | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 49.19 |
| Support Level | $7.68 | $26.50 |
| Resistance Level | $8.63 | $29.97 |
| Average True Range (ATR) | 0.38 | 1.72 |
| MACD | -0.10 | -0.17 |
| Stochastic Oscillator | 10.98 | 44.04 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.